Coloplast logo

Coloplast

North America, Minnesota, United States, Minneapolis

Description

Coloplast develops, manufactures, and markets medical devices and services related to ostomy, urology, continence, and wound care.

Investor Profile

Coloplast has backed more than 3 startups, with 1 new investments in the last 12 months alone. The firm has led 1 rounds, about 33% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Corporate Round, Series B, Series C rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Medical.

Stage Focus

  • Corporate Round (33%)
  • Series B (33%)
  • Series C (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Coloplast frequently co-invest with?

Solas BioVentures
North America, Tennessee, United States, Chattanooga
Co-Investments: 2
Co-Investments: 2
Orlando Health Ventures
North America, Florida, United States, Orlando
Co-Investments: 1
HV
North America, Tennessee, United States, Chattanooga
Co-Investments: 1
Arboretum Ventures
North America, Michigan, United States, Ann Arbor
Co-Investments: 2

What are some of recent deals done by Coloplast?

Francis Medical

Maple Grove, Minnesota, United States

Francis Medical is a medical technology company developing therapeutic solutions to treat prostate, kidney, and bladder cancer.

Medical
Series CJan 7, 2025
Amount Raised: $80,000,000
Francis Medical

Maple Grove, Minnesota, United States

Francis Medical is a medical technology company developing therapeutic solutions to treat prostate, kidney, and bladder cancer.

Medical
Series BSep 15, 2021
Amount Raised: $55,000,000
Francis Medical

Maple Grove, Minnesota, United States

Francis Medical is a medical technology company developing therapeutic solutions to treat prostate, kidney, and bladder cancer.

Medical
Corporate RoundSep 29, 2020
Amount Raised: $4,000,000